Ledger.Open graph →
SEC Form D · filed June 13, 2025

Fisher Wallace Laboratories, Inc

Offering
$5.0M
Sold
—
Exemption
Rule 506(c)
Industry
Biotechnology
Location
BROOKLYN, NY
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (4)

Kelly J. Roman · BROOKLYN, NYExec · DirectorCharles A. Fisher · BROOKLYN, NYDirectorCharles A. Fisher · BROOKLYN, NYDirectorKelly J. Roman · BROOKLYN, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗